FDA approves the first 3D printed drug

By using a 3D printer to manufacture the medication, up to 1,000mg can be administered in a single dose, making the administration of even the largest strengths of levetiracetam easier. In addition, each dose of SPRITAM is individually packaged, making it easier for patients to carry their medication on them. 

3D printing tablets enables medical professionals to better meet the needs of patients. While it has previously been too expensive to manufacture medication that meets specific needs, 3D printing allows medical professionals to adjust a patient’s dosage with the touch of a button.

3D printing is proving to be very useful in the healthcare sector. To date, doctors and dentists have used the technology to create customised implants such as replica jaws and teeth.

“By combining 3D printing technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,” said Don Wetherhold, CEO, Aprecia. “This is the first in a line of central nervous system products Aprecia plans to introduce as part of our commitment to transform the way patients experience taking medication.”